Nymox Corporation
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jul 2035
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Jan 2, 2027The maintenance fee for Compositions and methods for improving sexual function (US 10,335,453) comes due Jan 2, 2027. Unpaid by Jul 2, 2027, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 20, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 7 of 7
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,628,202 | Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia In force · From the USPTO record | In force | From the USPTO record | |
| US 12,746,268 | Combination Compositions for Treating Disorders Requiring Removal or Destruction of Unwanted Cellular Proliferations In force · High confidence | In force | High confidence | |
| US 10,172,910 | Method of Preventing or Reducing the Incidence of Acute Urinary Retention In force · High confidence | In force | High confidence | |
| US 10,183,058 | Method of Preventing or Reducing the Progression of Prostate Cancer In force · High confidence | In force | High confidence | |
| US 10,335,453 | Compositions and methods for improving sexual function In force · From the USPTO record | In force | From the USPTO record | |
| US 12,090,191 | Method of Enhancing the Therapeutic Efficacy of Fexapotide Triflutate in Treating Luts In force · Medium confidence | In force | Medium confidence | |
| US 12,329,802 | Focal treatment of prostate cancer In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 7: 14 lapsed for an unpaid fee · 13 ended at full term. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending · 1 abandoned · 3 no status recorded